Skip to content

Chain Drug Review

CVS Health beats Q3 earnings forecast

CVS Health beats Q3 earnings forecast

CVS Health turned in another impressive showing  in the third quarter of 2019, as both adjusted earnings and revenues exceeded analysts’ estimates. Based on the solid performance, the company raised its full-year guidance on adjusted earnings.

Arm & Hammer, OxiClean partner with The Laundry Chute

Arm & Hammer, OxiClean partner with The Laundry Chute

On average, college students spend 64 hours a year doing laundry – time that could be better spent studying or enjoying all that campus life has to offer. Recognizing the opportunity for a more convenient, high-quality laundry solution Arm & Hammer and OxiClean  laundry brands of Church & Dwight Co.

Higi partners with the American Diabetes Association

Higi partners with the American Diabetes Association

CHICAGO – Higi has teamed with the American Diabetes Association (ADA) to combat the large number of Americans with undiagnosed prediabetes or diabetes. Together, the two are offering a free and convenient self-service type 2 diabetes risk assessment at Higi Health Stations across its network.

ShopRite adds programs for Diabetes Awareness Month

ShopRite adds programs for Diabetes Awareness Month

November is Diabetes Awareness Month, and as part of ShopRite’s continued commitment to providing free health and wellness services to its shoppers, the supermarket is offering a variety of free diabetes-themed educational classes, food demonstrations and store tours led by its team of over 100 in-s

Camber Pharmaceuticals launches generic Bentyl

Camber Pharmaceuticals launches generic Bentyl

Camber Pharmaceuticals announced the addition of dicyclomine hydrochloride injectable to our growing portfolio of products. Dicyclomine hydrochloride Iinjectable is the generic version of Bentyl from Allergan and is used to treat functional bowel or irritable bowel syndrome.

Walgreens funds cancer research

Walgreens funds cancer research

Walgreens announced a new collaboration with Susan G. Komen and the Leukemia & Lymphoma Society (LLS) to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years.